| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CORT | Common Stock | Tax liability | $13,812 | -228 | -1.8% | $60.58 | 12,570 | 03 Mar 2025 | Direct | F1, F2, F3 |
| transaction | CORT | Common Stock | Award | $13,704 | +232 | +1.8% | $59.07 | 12,802 | 03 Mar 2025 | Direct | F3, F4, F5 |
| transaction | CORT | Common Stock | Award | $0 | +232 | +1.8% | $0.000000 | 13,034 | 03 Mar 2025 | Direct | F3, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CORT | Stock option (right to buy) | Award | $0 | +140,000 | $0.000000 | 140,000 | 28 Feb 2025 | Common Stock | 140,000 | $60.58 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. |
| F2 | The closing price on February 28, 2025 was used to calculate the withholding obligation. |
| F3 | Includes 1,448 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 400 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 231 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| F4 | The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on March 3, 2025. |
| F5 | In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. |
| F6 | Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. |
| F7 | Exercise ratably in equal installments on each monthly anniversary of February 28, 2025 over a four-year period subject to the Reporting Person's continued service through each vesting date. |
The power of attorney under which this form was signed is on file with the Commission.